Exclusive: Trial of Gilead's potential coronavirus treatment running ahead of schedule, researcher says
Details from a Chinese remdesivir trial in patients with severe COVID-19 inadvertently released by the WHO suggested it provided no benefit
UK to start trials on whether plasma could help COVID-19 patients
Up to 5,000 severely ill patients with COVID-19 could soon be treated each week with plasma as part of a new approach to treating the virus